Reason: Federal Court Demands Answers From DEA on Stonewalled Research Cannabis Applications

Disclaimer: This study was supported by funding from the Colorado Department of Public Health and Environment (CDPHE). The content and opinions are those of the grantee/authors and do not represent the official views of CDPHE.

Summary: Reason reports on a recent lawsuit against the Drug Enforcement Administration (DEA) filed by Dr. Sue Sisley, a MAPS-sponsored researcher who led a clinical trial of smoked cannabis for symptoms of PTSD. Three years ago, the DEA announced it would increase the number of federally approved cannabis growers for clinical research, but they have yet to respond to any of the applicants. The U.S. Court of Appeals for the District of Columbia Circuit has taken action and ordered the DEA to explain why they have delayed responding to applicants. The suit states, “agency action has been unlawfully withheld. And in view of an express directive to prioritize applications relating to clinical research, agency action has most certainly been unreasonably delayed.”

Originally appearing here.